Crinecerfont in a First Clinical Application of a CRH Antagonist: Further Potential Uses Are Still an Open Chapter!

Journal Article Crinecerfont in a First Clinical Application of a CRH Antagonist: Further Potential Uses Are Still an Open Chapter! Get access George P Chrousos George P Chrousos University Research Institute of Maternal and Child Health and Precision Medicine and UNESCO Chair on Adolescent Health Care, National and Kapodistrian University of Athens, Athens 11527, Greece Correspondence: George P. Chrousos, MD, University Research Institute of Maternal and Child Health and Precision Medicine and UNESCO Chair on Adolescent Health Care, National and Kapodistrian University of Athens, Choremeion Bldg, Children's Hospital Aghia Sophia, 8 Levadias St, Athens 11527, Greece. Email: chrousos@gmail.com or chrousge@med.uoa.gr. https://orcid.org/0000-0002-3098-5264 Search for other works by this author on: Oxford Academic Google Scholar The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 4, April 2024, Pages e1365–e1366, https://doi.org/10.1210/clinem/dgad513 Published: 31 August 2023 Article history Received: 13 July 2023 Editorial decision: 25 August 2023 Published: 31 August 2023 Corrected and typeset: 06 September 2023